Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086)

Clinical Trial ID NCT02447003

PubWeight™ 8.06^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02447003

Top papers